TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy

DSpace Repository

TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy

Author: Eckardt, Julia; Schroeder, Christopher; Martus, Peter; Armeanu-Ebinger, Sorin; Kelemen, Olga; Gschwind, Axel; Bonzheim, Irina; Eigentler, Thomas; Amaral, Teresa; Ossowski, Stephan; Riess, Olaf; Flatz, Lukas; Garbe, Claus; Forschner, Andrea
Tübinger Autor(en):
Eckardt, Julia
Schroeder, Christopher
Martus, Peter
Armeanu-Ebinger, Sorin
Kelemen, Olga
Gschwind, Axel
Bonzheim, Irina
Amaral, Teresa
Ossowski, Stephan
Riess, Olaf
Flatz, Lukas
Garbe, Claus
Forschner, Andrea Lydia
Published in: Journal of Cancer Research and Clinical Oncology (2023), Bd. 149, H. 2, S. 833-840
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00432-022-03939-w
ISSN: 0171-5216
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)